Cellink BioX6 Gen3 3-D bioprinter and accessories

PRE-SOLICITATION NOTICE OF INTENT

NON-COMPETITIVE

INTRODUCTION

PURSUANT TO FAR Subpart 5.2—Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION.   

THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL O­­­­­R OPEN COMPETITION (INCLUDING BRAND-NAME). 

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA) at the National Insitutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) intends to negotiate and award a purchase order of Cellink BioX6 Gen3 3-D bioprinter and accessories to: Cellink LLC, 155 Seaport Blvd, Unit 2B, Boston, MA 02210. The essential characteristics of the Cellink BioX6 Gen3 3-D bioprinter and accessories that limit the availability to a sole source is that this purchase is a direct replacement for an existing Celllink bioprinter and must match in form, fit, and function to allow the use of proprietary printer heads that will be retained.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 541714 Research and Development in Biotechnology (except Nano biotechnology). Number of Employees: 1000.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses of the Federal acquisition Requlation (FAR) currently in effect at https://www.acquisition.gov/

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures.

DESCRIPTION OF REQUIREMENT

Project Description

See Attachment 1 – Purchase Description

Purpose and Objectives

The purpose of this requirement is to procure a Cellink BioX6 Gen3 3-D bioprinter and accessories for NCATS.

Period of Performance

The anticipated delivery is July 30, 2024.

CLOSING STATEMENT

This synopsis is not a request for competitive proposals, however, interested parties may submit a capability statement for consideration.  

Responses to this Notice must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement.

In addition the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.  The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.  

All responses must be received by 12:00 PM EST June 12, 2024.Responses must be emailed to the Contracting Officer at patricia.dasilva@nih.gov and reference the Notice ID 75N95024Q00339.